ArticleJAC-antimicrobial resistance2026
Molecular epidemiology and antimicrobial resistance of extended-spectrum beta-lactamases-producing
Article in JAC-antimicrobial resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The Methods: Between April 2022 and March 2023, samples from neonates, mothers, healthcare workers and hospital environments were analysed. ECC isolates underwent European Committee on Antimicrobial Susceptibility Testing-guided antimicrobial susceptibility testing and whole-genome sequencing to determine sequence types (STs), resistance determinants, plasmids and phylogenetic relationships. Results: A total of 132 ESBL-producing ECC isolates were recovered, with the majority originating from environmental sources (65.9%, Conclusions: These findings demonstrate substantial MDR ECC colonization in neonatal wards, suggesting hospital environments as reservoirs for resistant ECC. Temporally clustered isolates across environmental and patient samples underscore the need for strengthened infection prevention and genomic surveillance.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.